Study of bcl-2 protein expression and the apoptosis phenomenon in neuroblastoma

Anticancer Research

Volumn 18, Issue 2 A, 1998, Pages 801-806

  Mejia, M Carmen ^a   Navarro, Samuel ^a   Pellin, Antonio ^a   Castel, Victoria ^b   Llombart Bosch, Antonio ^a  

^a UNIVERSITY OF VALENCIA   (Spain)

^b HOSPITAL UNIVERSITARIO LA FE   (Spain)

Author keywords

Apoptosis; bcl 2 expression; Neuroblastoma; Prognostic factors

Indexed keywords

CYCLINE; PROTEIN BCL 2;

APOPTOSIS; ARTICLE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; NEUROBLASTOMA; ONCOGENE C MYB; PRIORITY JOURNAL; PROTEIN EXPRESSION; SPAIN;

APOPTOSIS; GENES, MYC; HUMANS; NEUROBLASTOMA; PROTO-ONCOGENE PROTEINS C-BCL-2; TUMOR CELLS, CULTURED;

EID: 0031865895     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. Brodeur JM, Seeger RC and Barret A: International criteria for diagnosis, staging and response to treatment in patients with neuroblastoma. J Clin Oncol 6: 1874-1881, 1988.
2. Shimada H, Chatten J, Newton WA, Sachs N, Hamoud AB, Chiba T, Marsden HB and Misugi K: Histopathologic prognostic factors in neuroblastic tumors: Definition of subtypes of ganglioneuroblastoma and an age-linked classification of neuroblastomas. J Natl Can Inst 73: 405, 1984.
3. Brodeur GM, Seeger RC, Schwab M, Varmus HE and Bishop JM: Amplification of N-myc in untreated human neuroblastomas correlates with advanced disease stage. Science 224: 1121-1124, 1984.
4. Corvi R, Amler L, Savelyeva L, Gehring M and Schwab M: M-YCN is retained in single copy at chromosome 2 band p23-24 during amplification in human neuroblastoma cells. Proc Natl Acad Sci USA 91: 5523-5527, 1994.
5. Navarro S: Posibilidades actuales en el diagnóstico del neuroblastoma: Presentación de dos casos. Patología 25: 356-358, 1992.
6. Schleirmacher G, Peter M, Michon J, Hugot JP, Vielh P, Zucker JM, Magdelénat H, Thomas G and Delaterre O: Two distinct deleted regions on the short arm of chromosome I in neuroblastoma. Genes Chromosom Cancer 10: 275-281,1994.
7. Takeda O, Homma C, Maseki N, Sakurai M, Kanda N and Schwab M: There may be two tumor suppressor genes on chromosome arm 1p closely associated with biologically distinct subtypes of neuroblastoma. Genes Chromosom Cancer 10: 30-39,1994.
8. Nakagawara A, Arima M, Azar C, Scavarda N and Brodeur G: Inverse relationship between trk expression and N-myc amplification in human neuroblastomas. Cancer Res 52: 1364-1368, 1992.
9. Castle V, Heidelberg P, Bromberg J, Ou X, Dole M and Nuñez G: Expression of the apoptosis-suppressing protein bcl-2 in neuroblastoma is associated with unfavourable histology and N-myc amplification. Am J Pathol 143: 1543-1550,1993.
10. Pezzella F and Gatter K: What is the value of bcl-2 protein detection for histopathologists? Histopathology 26: 89-93, 1995.
11. Cline J: Overview: the nature of malignancy. In: Apoptosis and cell cycle control in cancer, basic mechanisms and implications for treating malignant diseases (Shaun N and Thomas B, eds). USA, BIOS Sc Pub, 1996, pp 131-148.
12. Evan G, Harrington E, McCarthy N, Gilbert C, Benedict M and Nunez G: Integrated control of cell proliferation and apoptosis by oncogenes. In: Apoptosis and cell cycle control in cancer, basic mechanisms and implications for treating malignant diseases (Shaun N and Thomas B, eds). USA, BIOS Sc Pub,1996, pp 109-129.
13. Kogner P, Barbany G, Persson H, Soderhall S, Ahstrom L and Bjork O: Expression of nerve growth factor receptor mRNAs and clinical response to retinoic acid in neuroblastoma. Prog Clin Biol Res 385: 147-153, 1994.
14. Pritchard J and Hickman J: Why does stage 4s neuroblastoma regress spontaneously? Lancet 344: 869-870, 1994.
15. Weinreb M, Day PJR, Niggli F, Raafat F and Mann JR: Bcl-2 oncoprotein in neuroblastoma. Lancet 345: 992-993, 1995.
16. Ikeda H, Hirato J, Akami M, Matsuyama S, Suzuki N, Takahashi A and Kuroiwa M: Bcl-2 oncoprotein expression and apoptosis in neuroblastoma. J Pediatr Surg 30: 805-808, 1995.
17. Castel V, Garcia-Miguel P, Melero C, Navajas A, Navarro S, Molina J, Badal MD, Ruiz-Jimenez JI, on behalf of the Spanish Neuroblastoma Study Group: The treatment of advanced neuroblastoma. Results of the Spanish Neuroblastoma Study Group (SNSG) studies. Eur J Cancer 4: 642-645, 1995.
18. Cattoretti G, Pileri S, Parraviccini C, Becker M, Poggi S, Bifulco C, Key G, D'Amato L, Sabattini E, Feudale E, Reynolds F, Gerde J and Rilke F: Antigen unmasked on formalin-fixed, paraffin-embedded tissue sections. J Path 171: 83-98, 1993.
19. Hsu SM, Raine L and Fanger H: Use of avidin-biotin-peroxidase techniques: A comparison between ABC and unlabelled antibody (PAP) procedures. J Histochem Cytochem 29: 577- 580, 1981.
20. Bratthauer G and Adams L: Immunohistochemistry: Antigen detection in tissue. In: Advanced Laboratory Methods in Histology and Pathology (Mikel U, ed). Washington, DC, Armed Forces Institute of Pathology, 1994, pp 3-40.
21. Sambrook J, Fritsch EF and Maniatis T: Analysis of genomic DNA by southern hybridization. In: Molecular Cloning: A Laboratory Manual (Nolan C, Ford N and Ferguson M, eds). New York, Cold Spring Harbor Lab Press, 1989, pp. 9.31.
22. Crabbe DCG, Peters J and Seeger RC: Rapid detection of MYCN gene amplification in neuroblastomas using the polymerase chain reaction. Diagn Mol Pathol 1: 229-234,1992.
23. Greil J: Lymphoma/Hematopathology: the Antibodies. In: Immunomicroscopy: A Diagnostic Tool for the Surgical Pathologist (Taylor C and Cote R, eds). Philadelphia, W.B. Saunders Company, 1994, pp 82-83.
24. Kawasaki H, Mukai K, Yajima S, Tanaka R, Takayama J, Takasaki Y and Ohira M: Prognostic value of proliferating cell nuclear antigen (PCNA) immunostaining in neuroblastoma. Med Pediatr Oncol 24: 300-304, 1995.
25. Ikegaki N, Katsumata M, Tsujimoto Y, Nakagawara A and Brodeur GM: Relationship between bcl-2 and myc gene expression in human neuroblastoma. Cancer Lett 91: 161-168, 1995.
26. Reed JC, Nowell PC and Hoover RG: Regulation of c-myc mRNA levels in normal human lymphocytes by modulators of cell proliferation. Proc Natl Acad Sci USA 82: 4221-4224, 1985.
27. Schwab M and Bishop M: Sustained expression of the human protooncogene MYCN rescues rat embryo cells from senescence. Proc Natl Acad Sci USA 85: 9585-9589, 1988.
28. Hockenberry DM, Zutter M, Hickey W, Nahm M and Korsemeyer S: Bcl-2 protein is topographically restricted in tissues characterized by apoptotic cell death. Proc Natl Acad Sci USA 88: 6961-6965, 1991.
29. Pileri S, Poggi E, Sabattini S, Santucci S, Melilli G, Falini B and Tosi P: Apoptosis as programmed cell death (PCD): Cupio dissolvi in cell life. Current Diag Patol 1: 48-55, 1994.
30. Hockenberry DM: Bcl-2, a novel regulator of cell death. Bioassays 17: 631-638, 1995.
31. Mejía MC, Navarro S, Pellín A, Castel V and Llombart-Bosch A: Expression of bcl-2 protein in, neuroblastoma and its relation with apoptotic phenomenon. Anticancer Res 17: 4013-4014, 1997.